Association of Systemic Immune Inflammation Index with All-Cause, Cardiovascular Disease, and Cancer-Related Mortality in Patients with Cardiovascular Disease: A Cross-Sectional Study
DOI: https://doi.org/10.2147/JIR.S402227
IF: 4.5
2023-03-07
Journal of Inflammation Research
Abstract:Shengjue Xiao, 1, &ast Zhenwei Wang, 1, &ast Ronghua Zuo, 2, &ast Yufei Zhou, 3 Yiqing Yang, 1 Tian Chen, 1 Naifeng Liu 1 1 Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China; 2 Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China; 3 Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Naifeng Liu, Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao, Nanjing, 210009, People's Republic of China, Tel +86 025 8327 2002, Email Objective: Our research was designed to investigate the relationship between systemic immune inflammation (SII) index and all-cause, cardiovascular disease (CVD), and cancer-related mortality in patients with CVD. Methods: We used the National Health and Nutrition Examination Survey data from 1999 to 2018 to conduct this study. The association between SII index and all-cause, CVD, and cancer-related mortality in patients with CVD was examined using restricted cubic splines (RCS), Cox proportional hazard models, and subgroup analysis, respectively. CVD was defined as a composite of five outcomes of CVD, including coronary heart disease (CHD), congestive heart failure (CHF), angina pectoris, myocardial infarction, and stroke. Additionally, the link between SII index and all-cause, CVD, and cancer-related mortality in patients with a composite of five outcomes of CVD was also explored. Results: In total, 5329 participants were included. The RCS also showed a U-curve correlation between SII index and the all-cause, CVD, and cancer-related mortality in patients with CVD. As compared with the individuals with lowest quartile of SII index, hazard ratios with 95% confidence intervals for all-cause, CVD, and cancer-related mortality across the quartiles were (1.202 (0.981, 1.474), 1.184 (0.967, 1.450), and 1.365 (1.115, 1.672)), (1.116 (0.815, 1.527), 1.017 (0.740, 1.398), and 1.220 (0.891, 1.670)), and (1.202 (0.981, 1.474), 1.184 (0.967, 1.450), and 1.365 (1.115, 1.672)), respectively, in the full-adjusted model. The SII index also had a U-shaped relationship with all-cause, CVD, and cancer-related mortality in patients with CHD, angina, and myocardial infarction. Additionally, the U-shaped relationship between SII index and all-cause, and cancer-related mortality also exists in CHF, and stroke. However, there was a positive linear correlation between SII index and CVD mortality in patients with CHF, and stroke. Conclusion: In the United States general population, the correlation between SII index and all-cause, CVD, and cancer-related mortality showed a U-shaped curve in patients with CVD. Keywords: all-cause mortality, cross-sectional study, cardiovascular disease mortality, cancer-related mortality, systemic immune inflammatory index Worldwide, cardiovascular diseases (CVD) are responsible for nearly one-third of all deaths and account for the majority of disease burdens. 1,2 There are many types of CVD, including heart vascular diseases, heart structure and function diseases, heart conduction system diseases. 3 Among them, congestive heart failure (CHF), coronary heart disease (CHD), angina pectoris, myocardial infarction (MI), and stroke are all CVD. Systemic inflammation caused by metabolic or immunological conditions is strongly linked to cardiovascular disease. 4 In addition, after CVD, cancer is the second leading cause of death in the world. 5 Similar to CVD, chronic inflammation is often associated with cancer initiation and progression. 6 Systemic immune inflammation (SII) index is a measure of systemic inflammation based on neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and has been shown to be promising. 7,8 There is a correlation between changes in gene expression in peripheral blood cells and various forms of systemic inflammation and immunosuppression, such as CVD. 9 Wingrove JA has found that peripheral-blood cell gene expression reflects coronary artery disease (CAD) severity and presence. 10 In addition, an analysis of gene expression and demographic characteristics could be useful for identifying obstructive CAD among nondiabetics without known CAD. 11 Deng MC and his team revealed that the expression of genes in peripheral blood mononuclear cel -Abstract Truncated-
immunology